biospecimen__admin__batch_number	345.53.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	11447728-4577-4B03-A207-0E35B22D2505
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-UB-A7MB-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-UB-A7MB-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-UB-A7MB-01A
biospecimen__bio__biospecimen_barcode_bottom	0160357091
biospecimen__bio__day_of_creation	13
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	09
biospecimen__bio__month_of_shipment	10
biospecimen__bio__pathology_report_file_name	TCGA-UB-A7MB.8B239487-4D0E-45EF-84EB-F61B23C42FE7.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A343
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-UB-A7MB
biospecimen__shared__patient_id	A7MB
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__ablation_type	Radiofrequency Ablation
clinical__ablation__bcr_ablation_barcode	TCGA-UB-A7MB-A69955
clinical__ablation__bcr_ablation_uuid	3A2D60D6-5CD4-43E6-957D-F2B0EF1EC49F
clinical__ablation__days_to_ablation_performed	365
clinical__ablation__days_to_embolization_performed	390
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Doxorubicin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Y-90 Therasphere
clinical__ablation__lesions_count	1
clinical__ablation__treatment_cycles_count	1
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	16F9A1C0-2ABA-42C1-BCFC-225F98E5B930
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	3.1
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.4
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.4
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	1865
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	140
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	24
clinical__clin_shared__bcr_followup_barcode	TCGA-UB-A7MB-F67159
clinical__clin_shared__bcr_followup_uuid	7220B0CF-105F-4956-A9AC-E0C7CB09C928
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	8
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	583
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	48
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-UB-A7MB-D63688
clinical__rx__bcr_drug_uuid	B5DB5B04-A285-4B4F-9677-5EF63DC2CC7A
clinical__rx__days_to_drug_therapy_end	510
clinical__rx__days_to_drug_therapy_start	123
clinical__rx__drug_name	oxaliplatin
clinical__rx__therapy_ongoing	YES
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a5160484-32db-40db-8c23-a9aeaae8f2b0
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-UB-A7MB-01A-11R-A343-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	ca0542b4-f7ee-40d1-97df-2b296da462b9
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.78
gdc__analytes__analyte_id	c4e187ed-147b-40ba-89e4-5b1f80843b0b
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	af1e56af-410c-4cad-a4e8-1c6937f1a350
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:34:57.516354-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	ac2093be-c88c-5c19-816b-320ba9a291a3
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1989
gdc__diagnoses__age_at_diagnosis	8951
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-8951.0
gdc__diagnoses__days_to_last_follow_up	601.0
gdc__diagnoses__diagnosis_id	25368ded-56a4-5c01-8e30-314d420f4c1a
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	19.1358024691358
gdc__exposures__exposure_id	06ac12f1-de7b-5cb6-ae04-9239890c94f7
gdc__exposures__height	180.0
gdc__exposures__weight	62.0
gdc__file_id	19cca660-045e-4339-9700-e7721724f32e
gdc__file_name	450198c1-92fc-4460-9430-eb9ab8458b50.mirbase21.mirnas.quantification.txt
gdc__file_size	50175
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	d7b301794f225d1fd07a86f20905e454
gdc__portions__is_ffpe	false
gdc__portions__portion_id	48367177-d4eb-44bd-b334-1ef185be6abc
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	176
gdc__samples__initial_weight	140.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	8B239487-4D0E-45EF-84EB-F61B23C42FE7
gdc__samples__sample_id	110dc5cc-bfe1-427d-87ef-037b719bf96f
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	a94aba6e-7e1c-4dc3-b79d-7cf0b3d0e6a5
gdc__submitter_id	mirna_swap_dr11_218_MirnaExpressiona0c2b216-8975-4a46-ae41-84eaa0a2f84d_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	UB
gdc__tissue_source_site__name	UCSF
gdc__tissue_source_site__tissue_source_site_id	2a8f962a-d2a8-5fb6-aea0-6bf694c0769c
gdc__treatments__treatment_id	23640b8c-827c-547b-b5f0-a28882b27cc9
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:22.083+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a5160484-32db-40db-8c23-a9aeaae8f2b0-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a5160484-32db-40db-8c23-a9aeaae8f2b0-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129546
manually_curated__local_md5	b68a3bb2dbf683f50c751df6191a66b8
manually_curated__opengdc_download_date	2018-10-16T17:11:44.000781+02:00
manually_curated__opengdc_file_md5	a92b2d1f8ba10abf3c6ea6184755376d
manually_curated__opengdc_file_size	50174
manually_curated__opengdc_id	a5160484-32db-40db-8c23-a9aeaae8f2b0-meq
manually_curated__origin_file_size	129546
manually_curated__origin_last_modified_date	Tue Oct 16 17:38:00 CEST 2018
manually_curated__origin_md5	b68a3bb2dbf683f50c751df6191a66b8
manually_curated__tissue_status	tumoral
